Document is current
Any future updates will be listed below
-
Authors
Eijsvogel, Pepijn http://orcid.org/0000-0003-2091-6481
Misra, Pinaki http://orcid.org/0000-0001-5185-1890
Concha-Marambio, Luis http://orcid.org/0000-0002-9454-8389
Boyd, Justin D.
Ding, Shuang
Fedor, Lauren
Hsieh, Yueh-Ting
Sun, Yu Shuang
Vroom, Madeline M. http://orcid.org/0000-0002-7560-359X
Farris, Carly M.
Ma, Yihua
de Kam, Marieke L.
Radanovic, Igor http://orcid.org/0000-0002-9486-4867
Vissers, Maurits F. J. M. http://orcid.org/0000-0001-7199-7301
Mirski, Dario
Shareghi, Ghazal
Shahnawaz, Mohammad
Singer, Wolfgang http://orcid.org/0000-0003-1263-6850
Kremer, Philip http://orcid.org/0000-0003-0483-841X
Groeneveld, Geert Jan
Yu, Hui Jing
Dodart, Jean-Cosme
-
Funding
Funding for this research was provided by:
Michael J. Fox Foundation for Parkinson’s Research (MJFF-020184, MJFF-020184, MJFF-020184)
Michael Fund International Foundation for Genetics Research (MJFF-020184)
- License Information
-
More Information
Article History
Received: 16 February 2024
Accepted: 30 May 2024
First Online: 20 June 2024
Competing interests
: P.E., P.K., I.R., M.V., M.L.d.K., M.F.J.M.V. and G.J.G. were employees of CHDR and conducted the study, and declare no competing interests. J.D.B., S.D., L.F., Y.-T.H., D.M., Y.S.S., M.M.V., H.J.Y. and J.-C.D. are employees at Vaxxinity, Inc, the study sponsor (or were at the time of the study) and hold company stock options. L.C.-M., C.M.F. and Y.M. are employees of Amprion Inc. L.C.-M., C.M.F., Y.M. and M.S. are named inventors of several patents and pending patent applications related to the αSyn-SAA. These patents and pending applications are either co-owned by Amprion with UT Health and exclusively licensed by Amprion Inc. or are owned solely by Amprion. The use of αSyn-SAA as described herein by Mayo Clinic is by limited permission only. All inquiries about the use of αSyn-SAA for diagnostic and/or drug development purposes should be directed to L.C.-M. P.M., G.S. and W.S. declare no competing interests.
